By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified ...

A major step towards simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...